Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NPT, EXE, AVO

FRC calls out Senate confirmation of abortion activist to head largest executive agency


WASHINGTON, March 18, 2021 /PRNewswire/ -- Family Research Council today stated the U.S. Senate's confirmation of Xavier Becerra as Secretary of Health and Human Services by a vote of 50-49 makes abundantly clear the Biden administration and the Democratic Party are using health care and the coronavirus as a cover for their political agenda. 

Family Research Council President Tony Perkins made the following remarks:

"We're disappointed to see the U.S. Senate hand the job of leading our nation out of the worst pandemic in 100 years to a man with zero training in medicine, science, pharma, or the health care world. The only real experience he has with the industry is suing hospitals, pregnancy care centers, and other entities that aren't pro-abortion enough for his liking. His extreme views are bad enough, but as attorney general of California, he forced those views on others, even after he was rebuked by the U.S. Supreme Court.

"As Senator James Lankford noted, President Biden could have chosen a better Secretary of Health and Human Services using LinkedIn. Instead, the man he chose is less than qualified for anything but aggressively targeting political adversaries. Biden promised to unite the country, and then he assigned the most radical advocate for the Left's pro-abortion, anti-First Amendment agenda he could find to lead the nation's largest executive agency. In his Senate hearings, Xavier Becerra refused to identify any policy to expand abortion he would oppose, and even refused to apologize for his past support for the barbaric practice of partial birth abortion," concluded Perkins.

Connor Semelsberger, Director of Federal Affairs for Life and Human Dignity at Family Research Council, added:

"The Department of Health and Human Services has the broadest authority of any agency over federal policies affecting abortion and conscience rights for health care providers. Xavier Becerra has made it clear through his nomination process that he does not intend to champion a unifying healthcare response to the pandemic, but rather he plans to export the pro-abortion policies he championed in California across the whole country. The radical policies, like the Obamacare contraception mandate that came from HHS during the Obama Administration, will pale in comparison to what we can expect with Becerra at the helm."

See our latest talking points and blog outlining Becerra's record on anti-life, anti-family policies.

SOURCE Family Research Council


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: